Developer docs
API playgroundTry for free, no card

Search company profiles

BioTools Innovator

Full company profile

uuid000647f

Namestring
BioTools Innovator
Legal namestring
BioTools Innovator
Company typeenum
Private
Founded yearint
2021
Descriptiontext

BioTools Innovator is a nonprofit accelerator founded in 2021 and headquartered in Los Angeles, California. It is the world's first accelerator dedicated exclusively to life science tools and diagnostics startups. The organization operates a four-month virtual mentorship program that selects 30-31 companies annually from a competitive applicant pool (~550 in 2026), providing tailored mentorship from senior industry leaders, a customized educational curriculum, peer networking, investor access, and competition for up to $300,000 in non-dilutive prize funding. The annual Capstone Event convenes 200+ industry leaders, investors, and executives for startup pitches, panel discussions, and the $250,000 Grand Prize Finals. The program is powered by MedTech Innovator, leveraging its 12+ years of accelerator experience and an alumni network that has brought 400+ products to market and raised $12B+ in follow-on funding.

The organization does not charge application fees or take equity from participating companies. Program funding comes from the Frederick Gardner Cottrell Foundation of Research Corporation Technologies (RCT), with additional support from BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific. BioTools Innovator has expanded into three specialized branded programs: VANGUARD (a joint initiative with BARDA launched in 2024 serving as the Enabling Technologies Hub of the BARDA Accelerator Network), ReadyDetect (a $5M two-stage prize competition launched in June 2026 for decentralized blood collection diagnostics), and Level UP-XR (a workforce training program for biopharmaceutical manufacturing technicians launched in December 2025). Kathryn Zavala serves as Managing Director.

Across five years of operation, BioTools Innovator has supported 94 cohort companies, awarded $1.44M in cash prizes, and catalyzed $200M in cumulative follow-on equity funding by alumni. Cohort applicants have grown from 400+ in 2025 to nearly 550 in 2026, with selected companies drawn from 43+ countries spanning North America, Europe, Asia Pacific, and Australia.

Short descriptiontext

BioTools Innovator is a nonprofit accelerator founded in 2021 that runs four-month virtual mentorship programs for early-stage life science tools and diagnostics startups, offering non-dilutive prize funding, senior industry mentorship, and access to a curated network of 200+ life science leaders at its annual Capstone Event.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science accelerator, biotech startup funding, diagnostics company development, nonprofit medtech accelerator, venture development program
Industry3 codes
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Other Scientific and Technical Consulting Services54169
  • Professional and Management Development Training611430
SIC code1 code
  • Investment Advice6282
Product category
Life Science Startup Accelerator
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Foundation and Grant Funding
TypeSubscription Recurring
Description

BioTools Innovator is funded by the Frederick Gardner Cottrell Foundation of Research Corporation Technologies, with additional support from BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific. The organization is a nonprofit accelerator that does not charge cohort companies application fees or take equity, relying on charitable contributions and program support from corporate partners and foundations to sustain operations.

biotoolsinnovator.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Non-dilutive accelerator program with up to $300K in prize-based funding
ModelOtherBilling cadenceMulti-year contract
Notes

No application fee, no equity taken. Cohort companies gain access to mentorship, educational curriculum, investor networking, and visibility at the Capstone Event. At program end, companies compete for $300,000 in cash prizes, with the Grand Prize winner receiving $250,000. The $250,000 Grand Prize has been awarded in multiple years (2025 winner: Eukarÿs). Additional $10,000 prizes awarded for Best Video and finalist recognition.

biotoolsinnovator.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1VANGUARD
Description

A joint initiative between BioTools Innovator and the Biomedical Advanced Research and Development Authority (BARDA), serving as the Enabling Technologies Hub of the BARDA Accelerator Network. Focuses on supporting innovations in drug discovery and development, biomanufacturing capabilities, diagnostics, and improved clinical research and care coordination.

biotoolsinnovator.org
+2 more records
Core offering1 text field

BioTools Innovator is a nonprofit virtual accelerator that runs a four-month cohort program selecting roughly 30-31 early-stage life science tools and diagnostics companies each year. Selected startups receive up to $300,000 in non-dilutive funding, mentorship, and a structured curriculum designed to accelerate commercialization and fundraising readiness. The program is powered by MedTech Innovator and supported by sponsors including Frederick Gardner Cottrell Foundation of RCT, BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • $200M in follow-on funding raised by BioTools Innovator alumni companies
+3 more records
Product overview1 text field

BioTools Innovator is the world's first nonprofit accelerator focused exclusively on life science tools and diagnostics companies, founded in 2021 and based in Los Angeles. The organization operates a four-month virtual mentorship program (the core Accelerator) that matches industry leaders with early-stage and emerging growth biotechnology companies for mentorship, funding opportunities, and peer engagement. The accelerator's portfolio includes three key branded programs: VANGUARD (a joint initiative with BARDA serving as the Enabling Technologies Hub of the BARDA Accelerator Network), the ReadyDetect Blood Sampling Competition ($5M prize competition for decentralized diagnostics), and the Level UP-XR Training Program (XR-based workforce training for biomanufacturing). Companies compete for up to $300,000 in non-dilutive funding, culminating in an annual Capstone Event featuring the $250,000 Grand Prize competition. The program is powered by MedTech Innovator and funded by the Frederick Gardner Cottrell Foundation of RCT with support from BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific.

Product and service4 records
1BioTools Innovator Core Accelerator Program
CategoryStartup Accelerator Program
Description

A four-month virtual accelerator cohort program that selects approximately 30-31 early-stage life science tools and diagnostics companies per year, providing mentorship, a structured curriculum, and up to $300,000 in non-dilutive funding per company. Designed for founder-led, pre-Series A startups in the life sciences tools/diagnostics niche.

2VANGUARD
CategorySpecialized Accelerator Track
Description

A specialized track within the BioTools Innovator program developed in partnership with BARDA, supporting companies whose life science tools and diagnostics align with public health preparedness and advanced research development priorities.

3ReadyDetect
CategoryDiagnostics Acceleration Program
Description

A BioTools Innovator program targeting diagnostics-focused startups, providing targeted commercialization support and resources tailored to companies developing diagnostic products.

4Level UP-XR
CategoryAccelerator Curriculum Program
Description

A BioTools Innovator program offering extended curriculum and development support aimed at accelerating participant progress within the accelerator ecosystem.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeOthersAnnounced on2025-01-01
Description

Perks partner providing services to BioTools Innovator cohort companies as part of the program's resource and perks offering.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Joint initiative partner for the VANGUARD program. BARDA, part of the Administration for Strategic Preparedness and Response within HHS, partners with BioTools Innovator through the BARDA Accelerator Network to support startups developing medical countermeasures. VANGUARD is the Enabling Technologies Hub of the BARDA Accelerator Network, providing cohort companies with BARDA subject matter expert access and up to $200K in additional non-dilutive funding.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Acceleration partner contributing to the BioTools Innovator ecosystem. Participates in cohort company selection and provides industry expertise as part of the program's corporate partner network.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Acceleration partner providing industry expertise and mentorship guidance. Participates in cohort selection committee and contributes to the program's expert ecosystem of mentors and judges.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Acceleration partner contributing to the BioTools Innovator program as part of the corporate partner network, providing industry perspective and mentorship to cohort companies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

BioTools Innovator is powered by MedTech Innovator (MTI), the world's largest accelerator of medical technology companies and premier nonprofit startup accelerator in the medical technology industry. MedTech Innovator provides the operational platform, ecosystem, and proven accelerator model that BioTools Innovator leverages. To date, MTI alumni have brought over 400 products to market and raised $12+ billion in follow-on funding. MTI's road tour, summit, and network infrastructure underpin BTI's operations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Y Combinator
TypeBroad incumbent
Description

Y Combinator is the world's largest generalist accelerator, with a growing life science and biotech presence through YC Bio. It is comparable as an accelerator offering seed funding, mentorship, and investor access to early-stage founders, but operates across all technology verticals and is not specialized in life science tools like BTI.

TypeOthers
Description

Creative Destruction Lab is a nonprofit seed-stage program for science and technology-based startups with a growing biotech stream. It is thematically comparable as a nonprofit, mentorship-driven startup program targeting science-based founders, though it operates across multiple technology verticals and uses an objectives-based milestone format rather than BTI's traditional accelerator cohort structure.

TypeBroad incumbent
Description

Techstars is a global accelerator network running numerous vertical-specific programs including healthcare and life science tracks. It is comparable as an established accelerator offering mentorship, capital, and a global network, but with broader industry scope and an equity-based model rather than BTI's nonprofit, non-dilutive approach.

TypeDirect peer
Description

MedTech Innovator is the parent organization that powers BioTools Innovator and operates the world's largest accelerator of medical technology companies. It is directly comparable as it runs a similar mentorship-driven, nonprofit accelerator model for medical devices and digital health, with 400+ products commercialized and $12B+ in alumni follow-on funding providing strong precedent for BTI's vertical extension.

TypeBroad incumbent
Description

Plug and Play is a global innovation platform and accelerator network with dedicated health and biotech verticals. It is comparable as a vertical-focused accelerator with extensive corporate partnerships, but operates across many industries with an equity-driven model rather than BTI's nonprofit, mentor-centric model.

TypeBroad incumbent
Description

JLABS is Johnson & Johnson's life science incubator network providing lab space, mentorship, and resources to healthcare startups globally. It is comparable as a life science-focused startup support organization serving similar customers, but operates as a corporate incubator with physical lab infrastructure rather than BTI's virtual, mentorship-driven accelerator model.

TypeRegional player
Description

MBC BioLabs is a Bay Area-based life science incubator providing shared wet lab space and entrepreneurship programming to early-stage biotech startups. It is comparable as a life science startup support organization serving the same US West Coast founder pool as BTI's primary applicant base, but focuses on physical lab infrastructure rather than virtual mentorship.

8Alexandria LaunchLabs
TypeRegional player
Description

Alexandria LaunchLabs is a life science startup incubator providing lab space, seed capital, and mentorship in Cambridge, MA and other biotech hubs. It is comparable as a life science startup support organization targeting similar founder customers, with a focus on physical infrastructure and seed capital in the Boston/Cambridge biotech cluster.

9California Life Sciences FAST
TypeRegional player
Description

California Life Sciences FAST is an advisory and accelerator program for early-stage life science companies in California. It is comparable as a life science startup support program with mentorship and investor connections targeting the same California-based founder pool as BTI, with a regional focus on the state's life sciences ecosystem.

TypeDirect peer
Description

IndieBio is a biotech accelerator supporting early-stage biology-driven startups with seed funding and mentorship. It is directly comparable as it serves a similar customer base (biology/biotech founders) with an accelerator model, though IndieBio typically takes equity and covers a broader biology range including synthetic biology and food tech rather than BTI's life science tools focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment81 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioTools Innovator

Life Science Startup Acceleratorbiotoolsinnovator.org

BioTools Innovator is a nonprofit accelerator founded in 2021 that runs four-month virtual mentorship programs for early-stage life science tools and diagnostics startups, offering non-dilutive prize funding, senior industry mentorship, and access to a curated network of 200+ life science leaders at its annual Capstone Event.

What BioTools Innovator does

BioTools Innovator is a nonprofit accelerator founded in 2021 and headquartered in Los Angeles, California. It is the world's first accelerator dedicated exclusively to life science tools and diagnostics startups. The organization operates a four-month virtual mentorship program that selects 30-31 companies annually from a competitive applicant pool (~550 in 2026), providing tailored mentorship from senior industry leaders, a customized educational curriculum, peer networking, investor access, and competition for up to $300,000 in non-dilutive prize funding. The annual Capstone Event convenes 200+ industry leaders, investors, and executives for startup pitches, panel discussions, and the $250,000 Grand Prize Finals. The program is powered by MedTech Innovator, leveraging its 12+ years of accelerator experience and an alumni network that has brought 400+ products to market and raised $12B+ in follow-on funding.

The organization does not charge application fees or take equity from participating companies. Program funding comes from the Frederick Gardner Cottrell Foundation of Research Corporation Technologies (RCT), with additional support from BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific. BioTools Innovator has expanded into three specialized branded programs: VANGUARD (a joint initiative with BARDA launched in 2024 serving as the Enabling Technologies Hub of the BARDA Accelerator Network), ReadyDetect (a $5M two-stage prize competition launched in June 2026 for decentralized blood collection diagnostics), and Level UP-XR (a workforce training program for biopharmaceutical manufacturing technicians launched in December 2025). Kathryn Zavala serves as Managing Director.

Across five years of operation, BioTools Innovator has supported 94 cohort companies, awarded $1.44M in cash prizes, and catalyzed $200M in cumulative follow-on equity funding by alumni. Cohort applicants have grown from 400+ in 2025 to nearly 550 in 2026, with selected companies drawn from 43+ countries spanning North America, Europe, Asia Pacific, and Australia.

BioTools Innovator firmographics

Firmographics
Name
BioTools Innovator
Legal name
BioTools Innovator
Website
https://biotoolsinnovator.org
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
BioTools Innovator is a nonprofit accelerator founded in 2021 that runs four-month virtual mentorship programs for early-stage life science tools and diagnostics startups, offering non-dilutive prize funding, senior industry mentorship, and access to a curated network of 200+ life science leaders at its annual Capstone Event.
Ownership category
akta.pro rank

BioTools Innovator industry classification

Industry
Product category
Life Science Startup Accelerator
NAICS
Other Scientific and Technical Consulting Services (54169), Professional and Management Development Training (611430)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Life science accelerator
  • Biotech startup funding
  • Diagnostics company development
  • Nonprofit medtech accelerator
  • Venture development program

Where BioTools Innovator is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BioTools Innovator business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Foundation and Grant Funding: BioTools Innovator is funded by the Frederick Gardner Cottrell Foundation of Research Corporation Technologies, with additional support from BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific. The organization is a nonprofit accelerator that does not charge cohort companies application fees or take equity, relying on charitable contributions and program support from corporate partners and foundations to sustain operations.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractNon-dilutive accelerator program with up to $300K in prize-based funding

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

BioTools Innovator product offering

Product offering

Core offering

BioTools Innovator is a nonprofit virtual accelerator that runs a four-month cohort program selecting roughly 30-31 early-stage life science tools and diagnostics companies each year. Selected startups receive up to $300,000 in non-dilutive funding, mentorship, and a structured curriculum designed to accelerate commercialization and fundraising readiness. The program is powered by MedTech Innovator and supported by sponsors including Frederick Gardner Cottrell Foundation of RCT, BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific.

Product overview

BioTools Innovator is the world's first nonprofit accelerator focused exclusively on life science tools and diagnostics companies, founded in 2021 and based in Los Angeles. The organization operates a four-month virtual mentorship program (the core Accelerator) that matches industry leaders with early-stage and emerging growth biotechnology companies for mentorship, funding opportunities, and peer engagement. The accelerator's portfolio includes three key branded programs: VANGUARD (a joint initiative with BARDA serving as the Enabling Technologies Hub of the BARDA Accelerator Network), the ReadyDetect Blood Sampling Competition ($5M prize competition for decentralized diagnostics), and the Level UP-XR Training Program (XR-based workforce training for biomanufacturing). Companies compete for up to $300,000 in non-dilutive funding, culminating in an annual Capstone Event featuring the $250,000 Grand Prize competition. The program is powered by MedTech Innovator and funded by the Frederick Gardner Cottrell Foundation of RCT with support from BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific.

Differentiator

Problem solved

Functional benefit

Brands

  • VANGUARD: A joint initiative between BioTools Innovator and the Biomedical Advanced Research and Development Authority (BARDA), serving as the Enabling Technologies Hub of the BARDA Accelerator Network. Focuses on supporting innovations in drug discovery and development, biomanufacturing capabilities, diagnostics, and improved clinical research and care coordination.
  • ReadyDetect
  • Level UP-XR

Products and services

  • BioTools Innovator Core Accelerator Program A four-month virtual accelerator cohort program that selects approximately 30-31 early-stage life science tools and diagnostics companies per year, providing mentorship, a structured curriculum, and up to $300,000 in non-dilutive funding per company. Designed for founder-led, pre-Series A startups in the life sciences tools/diagnostics niche.
  • VANGUARD A specialized track within the BioTools Innovator program developed in partnership with BARDA, supporting companies whose life science tools and diagnostics align with public health preparedness and advanced research development priorities.
  • ReadyDetect A BioTools Innovator program targeting diagnostics-focused startups, providing targeted commercialization support and resources tailored to companies developing diagnostic products.
  • Level UP-XR A BioTools Innovator program offering extended curriculum and development support aimed at accelerating participant progress within the accelerator ecosystem.

Quantifiable outcome

  • $200M in follow-on funding raised by BioTools Innovator alumni companies
  • +3 more outcomes

Companies that use BioTools Innovator

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

BioTools Innovator technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BioTools Innovator partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • PubGrademinorOthers · 1 January 2025Perks partner providing services to BioTools Innovator cohort companies as part of the program's resource and perks offering.
  • Biomedical Advanced Research and Development Authority (BARDA)coreStrategic or Co-development Partner · 1 January 2024Joint initiative partner for the VANGUARD program. BARDA, part of the Administration for Strategic Preparedness and Response within HHS, partners with BioTools Innovator through the BARDA Accelerator Network to support startups developing medical countermeasures. VANGUARD is the Enabling Technologies Hub of the BARDA Accelerator Network, providing cohort companies with BARDA subject matter expert access and up to $200K in additional non-dilutive funding.
  • Nissan Chemical America CorporationcoreStrategic or Co-development Partner · 1 January 2021Acceleration partner contributing to the BioTools Innovator ecosystem. Participates in cohort company selection and provides industry expertise as part of the program's corporate partner network.
  • Thermo Fisher ScientificcoreStrategic or Co-development Partner · 1 January 2021Acceleration partner providing industry expertise and mentorship guidance. Participates in cohort selection committee and contributes to the program's expert ecosystem of mentors and judges.
  • EcolabminorStrategic or Co-development Partner · 1 January 2021Acceleration partner contributing to the BioTools Innovator program as part of the corporate partner network, providing industry perspective and mentorship to cohort companies.
  • MedTech InnovatorcoreStrategic or Co-development Partner · 1 January 2021BioTools Innovator is powered by MedTech Innovator (MTI), the world's largest accelerator of medical technology companies and premier nonprofit startup accelerator in the medical technology industry. MedTech Innovator provides the operational platform, ecosystem, and proven accelerator model that BioTools Innovator leverages. To date, MTI alumni have brought over 400 products to market and raised $12+ billion in follow-on funding. MTI's road tour, summit, and network infrastructure underpin BTI's operations.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

BioTools Innovator competitors and assessment

Company assessment

Broad incumbents

  • Y Combinator: Y Combinator is the world's largest generalist accelerator, with a growing life science and biotech presence through YC Bio. It is comparable as an accelerator offering seed funding, mentorship, and investor access to early-stage founders, but operates across all technology verticals and is not specialized in life science tools like BTI.
  • Techstars: Techstars is a global accelerator network running numerous vertical-specific programs including healthcare and life science tracks. It is comparable as an established accelerator offering mentorship, capital, and a global network, but with broader industry scope and an equity-based model rather than BTI's nonprofit, non-dilutive approach.
  • Plug and Play: Plug and Play is a global innovation platform and accelerator network with dedicated health and biotech verticals. It is comparable as a vertical-focused accelerator with extensive corporate partnerships, but operates across many industries with an equity-driven model rather than BTI's nonprofit, mentor-centric model.
  • Johnson & Johnson Innovation (JLABS): JLABS is Johnson & Johnson's life science incubator network providing lab space, mentorship, and resources to healthcare startups globally. It is comparable as a life science-focused startup support organization serving similar customers, but operates as a corporate incubator with physical lab infrastructure rather than BTI's virtual, mentorship-driven accelerator model.

Others

  • Creative Destruction Lab: Creative Destruction Lab is a nonprofit seed-stage program for science and technology-based startups with a growing biotech stream. It is thematically comparable as a nonprofit, mentorship-driven startup program targeting science-based founders, though it operates across multiple technology verticals and uses an objectives-based milestone format rather than BTI's traditional accelerator cohort structure.

Direct peers

  • MedTech Innovator: MedTech Innovator is the parent organization that powers BioTools Innovator and operates the world's largest accelerator of medical technology companies. It is directly comparable as it runs a similar mentorship-driven, nonprofit accelerator model for medical devices and digital health, with 400+ products commercialized and $12B+ in alumni follow-on funding providing strong precedent for BTI's vertical extension.
  • IndieBio: IndieBio is a biotech accelerator supporting early-stage biology-driven startups with seed funding and mentorship. It is directly comparable as it serves a similar customer base (biology/biotech founders) with an accelerator model, though IndieBio typically takes equity and covers a broader biology range including synthetic biology and food tech rather than BTI's life science tools focus.

Regional players

  • MBC BioLabs: MBC BioLabs is a Bay Area-based life science incubator providing shared wet lab space and entrepreneurship programming to early-stage biotech startups. It is comparable as a life science startup support organization serving the same US West Coast founder pool as BTI's primary applicant base, but focuses on physical lab infrastructure rather than virtual mentorship.
  • Alexandria LaunchLabs: Alexandria LaunchLabs is a life science startup incubator providing lab space, seed capital, and mentorship in Cambridge, MA and other biotech hubs. It is comparable as a life science startup support organization targeting similar founder customers, with a focus on physical infrastructure and seed capital in the Boston/Cambridge biotech cluster.
  • California Life Sciences FAST: California Life Sciences FAST is an advisory and accelerator program for early-stage life science companies in California. It is comparable as a life science startup support program with mentorship and investor connections targeting the same California-based founder pool as BTI, with a regional focus on the state's life sciences ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

BioTools Innovator social profiles

Digital presence

BioTools Innovator financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioTools Innovator leadership team

Management profile

Number of profiles

Profiles1 record

BioTools Innovator funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioTools Innovator M&A and investment

M&A and investment

M&A

Investments81 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioTools Innovator

What does BioTools Innovator do?

BioTools Innovator is a nonprofit virtual accelerator that runs a four-month cohort program selecting roughly 30-31 early-stage life science tools and diagnostics companies each year. Selected startups receive up to $300,000 in non-dilutive funding, mentorship, and a structured curriculum designed to accelerate commercialization and fundraising readiness. The program is powered by MedTech Innovator and supported by sponsors including Frederick Gardner Cottrell Foundation of RCT, BroadOak Capital Partners, Nissan Chemical America Corporation, and Thermo Fisher Scientific.

Is BioTools Innovator a public or private company?

BioTools Innovator is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was BioTools Innovator founded?

BioTools Innovator was founded in 2021. It employs 11 to 50 people.

Where is BioTools Innovator based?

BioTools Innovator is headquartered in Los Angeles, United States, in the North America region.

How does BioTools Innovator make money?

One revenue line is on record: foundation and Grant Funding.

Who are BioTools Innovator's main competitors?

Broad incumbents on record are Y Combinator, Techstars, Plug and Play and Johnson & Johnson Innovation (JLABS). Creative Destruction Lab is listed as an others. Direct peers are MedTech Innovator and IndieBio. Regional players are MBC BioLabs, Alexandria LaunchLabs and California Life Sciences FAST.

Does BioTools Innovator have an API?

No public API is recorded for BioTools Innovator.

What industry is BioTools Innovator in?

BioTools Innovator's product category is Life Science Startup Accelerator. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 54169 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireeGlint Wins 2026 BioTools Innovator Grand Prize, Recognizing Its Breakthrough in Rapid, Distributed ProteomicseGlint won the 2026 BioTools Innovator Grand Prize, receiving $250,000 at the San Diego competition. The award recognizes its ProteoNex biosensor platform, which delivers rapid protein measurements in about 10 minutes. The company plans to commercialize ProteoMix and expand into clinical diagnostics.Business Wire BlogBioTools Innovator Announces the 2026 Grand Prize and Best Video Winners at the Annual Capstone EventBioTools Innovator announced its 2026 Grand Prize winner at the annual Capstone Event in San Diego. eGlint Proteomics won $250,000 for its ProteoMix platform, which delivers multiplexed protein results in 10 minutes on existing qPCR instruments. EXIT071 won Best Video with a $10,000 prize.FinancialContent Business PageBioTools Innovator Announces the 2026 Grand Prize and Best Video Winners at the Annual Capstone EventeGlint Proteomics won the $250,000 Grand Prize at BioTools Innovator's 2026 Capstone Event in San Diego, with EXIT071 taking Best Video. The prize funds a proteomics platform that delivers multiplexed protein results in ten minutes on existing qPCR instruments. The event also awarded $10,000 to EXIT071 and selected 30 companies from 540 applicants.Business Wire BlogBioTools Innovator Announces the 2026 FinalistsBioTools Innovator announced four finalists for its 2026 program, selected from 30 companies out of 500 applicants. The finalists will compete for a $250,000 Grand Prize at the Capstone Event on October 14 in San Diego. The companies include Caravel, eGlint, Pando Bioscience, and QuantumCyte.PR NewswireEvoworks Bio Selected for BARDA-Backed VANGUARD Program to Demonstrate Rapid, Scalable Production of Critical BiologicsEvoworks Bio was selected for a BARDA-backed VANGUARD program to demonstrate rapid, scalable production of critical biologics. The 6-month project, with Kemp Proteins and Rockland Immunochemical, aims to cut quality-scale-up costs by 75% and validate antibodies on the EvoNode platform.EIN PresswirePrecision Quantomics Selected for BioTools Innovator 2026 Accelerator ProgramPrecision Quantomics was selected for the BioTools Innovator 2026 Accelerator Program, which provides mentorship and resources for life science tools. The company's quantitative proteomics solutions support drug development and New Approach Methodologies. The selection follows recent support from Spokane County's Health Sciences & Services Authority.startupticker.chSwiss startups win international awards for their precision solutionsSwiss deep-tech company Verity won the 2026 IERA Award for its fully autonomous indoor drone system used in warehouse inventory management, with systems now deployed in approximately 200 warehouses worldwide capturing 500,000 images per day. EPFL spin-off ORYL Photonics and CSEM jointly won the EARTO Innovation Award 2026 for developing an industrial prototype that uses light-based technology for high-throughput drug solubility testing, which accelerates drug candidate identification in pharmaceutical research. Additionally, Swiss startups Bioscibex and ENANTIOS were selected from nearly 550 applicants to join the BioTools Innovator 2026 cohort, gaining access to mentorship and $300,000 in competing funding.Business Wire BlogBioTools Innovator VANGUARD Launches ReadyDetect Blood Sampling Collection Prize CompetitionBioTools Innovator VANGUARD, in partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA), announced the launch of the ReadyDetect Blood Sampling Competition to advance innovative blood self-collection and sample preparation technologies for decentralized diagnostic testing in home, community, and field settings. The two-stage competition offers Concept Stage prizes of $100,000 for up to five winners and Prototype Stage prizes of $1,500,000 for up to three winners, with Concept Stage applications open through July 31, 2026. The initiative aims to expand access to diagnostic testing while strengthening national preparedness capabilities for public health emergencies.FinancialContent Business PageBioTools Innovator VANGUARD Launches ReadyDetect Blood Sampling Collection Prize CompetitionBioTools Innovator VANGUARD and BARDA announced the launch of ReadyDetect, a two-stage prize competition to advance blood self-collection and sample preparation technologies for decentralized diagnostic testing. The Concept Stage will award up to five winners $100,000 each, while the Prototype Stage will award up to three winners $1,500,000 each, with Concept Stage applications open through July 31, 2026. The initiative aims to strengthen national health preparedness capabilities and expand access to diagnostic testing in home, community, and field settings.NinediagnosticsNine Diagnostics Pitches at BioTools Innovator East Coast Road TourNine Diagnostics pitched its AI-enabled multi-omic nanosensor platform at the BioTools Innovator East Coast Pitch Event. The platform uses machine learning to generate molecular fingerprints from proteomic, metabolomic, and lipidomic data without predefined biomarkers. The company aims to validate the platform through research partnerships and build a commercialization pathway toward laboratory-developed tests.